stella
beta
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT — Stella
Recruiting
Back to Primary Immunodeficiency (PID) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
View full record on ClinicalTrials.gov